RGS14: Regulator of G Protein Signaling 14
A multifunctional signaling protein linking G protein pathways to neuronal plasticity and cancer
Gene Information Card
| Symbol | RGS14 |
|---|---|
| Full Name | Regulator of G Protein Signaling 14 |
| Gene Type | protein-coding |
| Chromosomal Location | 5q35.3 |
| NCBI Gene ID | 10636 ncbi.nlm.nih.gov/gene/10636 |
| Ensembl ID | ENSG00000169249 |
| UniProt ID | O43566 |
| OMIM ID | 602513 |
| HGNC ID | 9994 |
| Aliases | RGS14, FLJ12627, MGC117314 |
Description
RGS14 (Regulator of G Protein Signaling 14) is a protein-coding gene located on chromosome 5q35.3. It encodes a 547-amino acid protein that functions as a GTPase-activating protein (GAP) for Gαi/o subunits, thereby attenuating G protein-coupled receptor (GPCR) signaling. RGS14 also contains a GoLoco motif that binds Gαi-GDP, and two Ras-binding domains (RBDs) that link to Ras/MAPK pathways. The protein is highly expressed in the brain, particularly in hippocampal CA2 neurons, where it regulates synaptic plasticity, spatial learning, and memory. RGS14 has been implicated in cancer, neurological disorders, and cardiovascular function.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cancer (multiple types) | RGS14 mutations and altered expression may dysregulate GPCR and Ras signaling, promoting cell proliferation and metastasis. | COSMIC; PubMed studies |
| Alzheimer's disease | Reduced RGS14 expression in hippocampus may impair synaptic plasticity and memory. | ClinVar; PubMed |
| Schizophrenia | RGS14 variants associated with altered GPCR signaling in prefrontal cortex. | ClinVar; PubMed |
| Hypertension | RGS14 modulates angiotensin II signaling in vascular smooth muscle. | PubMed |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain (hippocampus) | 12.5 | High |
| Brain (cerebral cortex) | 8.2 | Medium |
| Testis | 6.1 | Medium |
| Heart | 3.4 | Low |
| Liver | 1.2 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| SH-SY5Y (neuroblastoma) | 9.8 | Neuronal model |
| HEK293 (embryonic kidney) | 7.5 | Common overexpression system |
| MCF7 (breast cancer) | 5.3 | ER+ breast cancer |
| A549 (lung cancer) | 4.1 | Lung adenocarcinoma |
| HepG2 (liver cancer) | 2.0 | Hepatocellular carcinoma |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1015C>T (p.Arg339Trp) | Missense | 0.02% (gnomAD) | Alters GoLoco motif; reduced Gαi binding |
| c.1234G>A (p.Gly412Ser) | Missense | 0.01% (COSMIC) | Found in colorectal cancer; functional impact unknown |
| c.1462_1463insA (p.Thr488Asnfs*12) | Frameshift | <0.01% (COSMIC) | Loss of C-terminal RBD; likely loss-of-function |
| c.788A>G (p.Asn263Ser) | Missense | 0.005% (ClinVar) | Associated with schizophrenia; altered GAP activity |
Mutation functional classification
Loss of Function (LOF)
Frameshift and nonsense mutations (e.g., p.Thr488Asnfs*12) truncate the protein, eliminating Ras-binding domains and GoLoco motif, leading to loss of GAP activity and impaired GPCR regulation.
Gain of Function (GOF)
Missense mutations in the RGS domain (e.g., p.Arg339Trp) may reduce GAP activity, prolonging Gαi-GTP signaling and potentially enhancing downstream pathways.
Dominant Negative (DN)
Mutations that disrupt GoLoco or RBD domains without complete loss of protein could interfere with wild-type RGS14 function, acting in a dominant-negative manner.
View complete mutation data:
Gene Ontology (GO)
Pathways
• GPCR signaling (RGS family)
• Ras/MAPK signaling
• Gαi/o signaling cascade
• Synaptic plasticity (hippocampal CA2)
Protein Summary
RGS14 is a 547-amino acid protein (UniProt O43566) that contains an N-terminal RGS domain (GAP activity for Gαi/o), a central GoLoco motif (binds Gαi-GDP), and two C-terminal Ras-binding domains (RBD1 and RBD2). It localizes to the cytoplasm and nucleus, and in neurons it is enriched at postsynaptic densities. RGS14 integrates GPCR and Ras signaling, modulating synaptic plasticity, long-term potentiation (LTP), and spatial memory. In cancer, altered RGS14 expression or mutation can disrupt these pathways, contributing to tumor progression.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| RGS14 Knockout HEK293 Cell Line | EDJ-KQ1349 | Human | 10636 | Details Get a Quote |
| RGS14 Knockout A-549 Cell Line | EDJ-KQ20824 | Human | 10636 | Details Get a Quote |
| RGS14 Knockout HCT 116 Cell Line | EDJ-KQ20825 | Human | 10636 | Details Get a Quote |
| RGS14 Knockout HeLa Cell Line | EDJ-KQ20826 | Human | 10636 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records